BiomX Inc.
Clinical-stage company developing phage therapies to target harmful bacteria.
PHGE | US
Overview
Corporate Details
- ISIN(s):
- US09090D1037
- LEI:
- Country:
- United States of America
- Address:
- 22 EINSTEIN ST., 7414003 NESS ZIONA
- Website:
- https://www.biomx.com/
- Sector:
- Manufacturing
Description
BiomX Inc. is a clinical-stage company developing phage therapies to target and destroy harmful bacteria. The company creates both natural and engineered phage cocktails and personalized treatments for chronic diseases. Its therapeutic pipeline focuses on conditions such as cystic fibrosis and diabetic foot osteomyelitis. BiomX's platform discovers and validates proprietary bacterial targets, allowing for the customization of phage compositions against these specific pathogens.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all BiomX Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BiomX Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BiomX Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
